Mice deficient in both pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide survive, but display growth retardation and sex-dependent early death

Journal of Molecular Neuroscience

Volumn 36, Issue 1-3, 2008, Pages 200-207

  Niewiadomski, Pawel ^a   Coûté Monvoisin, Anne Claire ^a   Abad, Catalina ^a   Ngo, Danny ^a   Menezes, Adrian ^a   Waschek, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dwarf; Growth; Growth hormone; IGF 1; Knockout; PACAP; Pituitary adenylyl cyclase activating polypeptide; Postnatal; Vasoactive intestinal peptide; VIP

Indexed keywords

GROWTH HORMONE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; SOMATOMEDIN C; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRTH WEIGHT; BRAIN SIZE; CONTROLLED STUDY; FEMALE; GROWTH RATE; GROWTH RETARDATION; MALE; MOUSE; NONHUMAN; POSTNATAL GROWTH; PROTEIN FUNCTION; WEANING; WILD TYPE;

ANIMALS; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; MALE; MICE; MICE, KNOCKOUT; PHENOTYPE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; SOMATOMEDINS; SURVIVAL RATE; VASOACTIVE INTESTINAL PEPTIDE;

MUS;

EID: 58149096613     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-008-9085-3     Document Type: Article

References (23)

1. C. Abad P. Niewiadomski D. H. -W. Loh J. A. Waschek 2006 Neurotransmitter and immunomodulatory actions of VIP and PACAP: lessons from knockout mice International Journal of Peptide Research and Therapeutics 12 297 310
2. M. A. Asnicar A. Koster M. L. Heiman F. Tinsley D. P. Smith E. Galbreath 2002 Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate Endocrinology 143 3994 4006
3. C. S. Colwell S. Michel J. Itri W. Rodriguez J. Tam V. Lelievre 2003 Disrupted circadian rhythms in VIP- and PHI-deficient mice American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 285 R939 949
4. C. S. Colwell S. Michel J. Itri W. Rodriguez J. Tam V. Lelievre 2004 Selective deficits in the circadian light response in mice lacking PACAP American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 287 R1194 1201
5. M. Delgado D. Pozo D. Ganea 2004 The significance of vasoactive intestinal peptide in immunomodulation Pharmacological Reviews 56 249 290
6. M. Desai N. J. Crowther A. Lucas C. N. Hales 1996 Organ-selective growth in the offspring of protein-restricted mothers British Journal of Nutrition 76 591 603
7. B. A. Girard V. Lelievre K. M. Braas T. Razinia M. A. Vizzard Y. Ioffe 2006 Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice Journal of Neurochemistry 99 499 513
8. S. L. Gray K. J. Cummings F. R. Jirik N. M. Sherwood 2001 Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism Molecular Endocrinology 15 1739 1747
9. S. L. Gray N. Yamaguchi P. Vencova N. M. Sherwood 2002 Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide Endocrinology 143 3946 3954
10. P. Gressens J. M. Hill I. Gozes M. Fridkin D. E. Brenneman 1993 Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos Nature 362 155 158
11. P. Gressens J. M. Hill B. Paindaveine I. Gozes M. Fridkin D. E. Brenneman 1994 Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse Journal of Clinical Investigation 94 2020 2027
12. C. Hamelink O. Tjurmina R. Damadzic W. S. Young E. Weihe H. W. Lee 2002 Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis Proceedings of the National Academy of Sciences of the United States of America 99 461 466
13. H. Hashimoto N. Shintani K. Tanaka W. Mori M. Hirose T. Matsuda 2001 Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) Proceedings of the National Academy of Sciences of the United States of America 98 13355 13360
14. Institute of Laboratory Animal Resources (U.S.) (1996). Guide for the care and use of laboratory animals. Washington, D.C.: National Academy.
15. F. Jamen K. Persson G. Bertrand N. Rodriguez-Henche R. Puech J. Bockaert 2000 PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance Journal of Clinical Investigation 105 1307 1315
16. V. Lelievre G. Favrais C. Abad H. Adle-Biassette Y. Lu P. M. Germano 2007 Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease Peptides 28 1688 1699
17. Lim, L. M., Stack, C. M., Cuasay, K., Stone, M. N., McFarlane, H. G., Waschek, J. A., et al. (2008). Regardless of genotype, offspring of VIP deficient female mice exhibit developmental delays and deficits in social behavior. International Journal of Developmental Neuroscience.
18. E. M. Lutz E. Ronaldson P. Shaw M. S. Johnson P. J. Holland R. Mitchell 2006 Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP Molecular and Cellular Neurosciences 31 193 209
19. C. Otto L. Hein M. Brede R. Jahns S. Engelhardt H. J. Grone 2004 Pulmonary hypertension and right heart failure in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice Circulation 110 3245 3251
20. L. E. Underwood J. P. Thissen S. Lemozy J. M. Ketelslegers D. R. Clemmons 1994 Hormonal and nutritional regulation of IGF-I and its binding proteins Hormone Research 42 145 151
21. D. Vaudry B. J. Gonzalez M. Basille L. Yon A. Fournier H. Vaudry 2000 Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions Pharmacological Reviews 52 269 324
22. J. Y. Wu K. A. Henins P. Gressens I. Gozes M. Fridkin D. E. Brenneman 1997 Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period Peptides 18 1131 1137
23. Y. Zhou B. C. Xu H. G. Maheshwari L. He M. Reed M. Lozykowski 1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse) Proceedings of the National Academy of Sciences of the United States of America 94 13215 13220